Skip to content
New in Press Releases

KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers

Read
Press Releases

KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers

LONDON, ON (May 26, 2020) – KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth’s CARDIO ...

Learn More
Press Releases

Largest North American Clinical Trial on Probiotic Strains for IBS Symptoms Conducted by KGK Science

LONDON, ON (May 19, 2020) – The findings from a clinical trial conducted by KGK Science studying the impact of two single strain probiotics on ...

Learn More
Press Releases

KGK Science Named Best Nutraceutical and Cannabinoid Full-Service CRO 2020 By Global Health & Pharma

LONDON, ON (April 14, 2020) – KGK Science has been recognized by the Global Health & Pharma (GHP) Medical Marijuana Awards as the Best Nutraceutical ...

Learn More
Blogs

Combating the Pandemic with Validated COVID-19 Test Kits

A recent USA Today article concerning the distribution of at-home coronavirus testing kits highlighted the confusion over what testing kits the FDA finds to be ...

Learn More
Press Releases

KGK Science President & CEO Joins International Probiotics Association Board of Directors

Najla Guthrie, President & CEO of KGK Science, has joined the International Probiotics Association (IPA) Board of Directors, effective April 2020. A global non-profit organization ...

Learn More
Press Releases

New Cannabis Research from KGK Science Published in Translational Neuroscience

Changing the Tone of Clinical Study Design in the Cannabis Industry The latest cannabis research from KGK Science has been published in the premier research ...

Learn More
Blogs

Picking Your Business Dance Partner: The New Age of Contractual Relationships

Last week, e-commerce giant Amazon took aim at own label distributors (OLDs) selling e-tailed products after the fallout from an injunction filed by the U.S. ...

Learn More
Press Releases

KGK Science Clinic During COVID-19

As the status of the COVID-19 pandemic continues to evolve, KGK Science remains committed to the health and safety of our clinical trial participants and ...

Learn More
Blogs

Athlete Immunity and Silver Hydrosol

Athlete Immunity and Silver Hydrosol: Frequently Asked Questions With all the health benefits of staying active, we would think that exercise would make us less ...

Learn More
Blogs

KGK Staff Profile: Registered Dietitian, Nicole Clouthier

It’s officially Nutrition Month so our first KGK staff profile is our new in-house registered dietitian, Nicole Clouthier.  Learn about Nicole and her favourite buttery ...

Learn More
Blogs

Innovating Cannabis Impairment Testing: An Interview with Israel Gasperin

Our current cannabis trial is looking at an innovative impairment testing device called the Cognalyzer™. We were able to sit down and talk with its ...

Learn More
Whitepapers

Regulatory Considerations for Probiotic Path-to-Market

This latest whitepaper by regulatory experts from KGK Science explores the regulatory pathways that can be taken by manufacturers of products containing new probiotic strains ...

Download
Whitepapers

More Than a Gut Feeling

Research on the microbiome has exploded due to new techniques that enable the identification of bacterial species without isolating and culturing a process highly limited ...

Download
Whitepapers

Avoiding a Regulatory Nightmare

Conducting a clinical trial in the health nutrition industry can be an important step towards boosting the reputation and sales of your dietary supplement product. ...

Download
Whitepapers

Probiotics and Infant Nutrition – Making Claims on the Foundation of Research

The market for infant formula has expanded over the past decade and competition is high amongst leading manufacturers to make claims that differentiate their products ...

Download
Whitepapers

Legal Marijuana – Canada’s Green Rush

A total of 147 million people, 2.5% of the world population, consume cannabis (annual prevalence) compared with 0.2% consuming cocaine and 0.2% consuming opiates. The ...

Download
Whitepapers

From Pipe Dream to Responsible Industry

An in-depth look at the regulatory path forward for hemp-derived cannabinoids in the USA and other markets, and the health benefits that consumers stand to ...

Download
Press Releases

KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device

KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device KGK Science has been contracted by the Hamilton, Ontario-based neurotech firm, Zentrela Inc. ...

Learn More
Press Releases

KGK Science CEO Joins Natural Products Canada Board of Directors

KGK Science announced the appointment of its President and CEO, Najla Guthrie, to the Board of Directors for Natural Products Canada (NPC). As a leader ...

Learn More
Webinars

Regulatory Considerations for Probiotic Path-to-Market

Tuesday, January 28, 2020 | (Tuesday) 1pm EST (10am PST) 60 min | REGISTER NOW The global probiotic market stands at just over $41 billion ...

Learn More
Blogs

KGK Goes Big on Scientific and Regulatory Expertise at NPA’s The Big Natural Show

The Natural Product Association (NPA) hosted its 3rd Annual The Big Natural conference last week just outside of Washington, D.C., a 2-day event bringing together the most ...

Learn More
Blogs

4th Annual IPA Probiotics Workshop

Q&A with KGK CEO Najla Guthrie and George Paraskevakos of IPA October 31st, 2019 is the 4th Annual IPA Probiotics Workshop in DC. As the ...

Learn More
Press Releases

KGK Science Leads the Nutraceutical Industry into a New Era of Scientific and Statistical Concepts

LONDON, ON (October 29, 2019) – A significant shift has taken place in scientific and statistical concepts in the nutraceutical space – a shift that ...

Learn More
Blogs

Are Your Cannabis Edibles Set Up for Sweet Success?

With the new regulations and guidelines surrounding cannabis edibles, it can be difficult to know exactly how to formulate, package, and test them to ensure ...

Learn More
Press Releases

KGK Science Grows with the Addition of Dr. Corey Hilmas as Chief Regulatory Officer

LONDON, ON (October 2019) – KGK Science Inc. (“KGK”) is a different company than it was in 2018. Following their acquisition by Auxly Cannabis Group Inc. ...

Learn More
Press Releases

KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech

LONDON, ON (September 10, 2019) – KGK Science Inc. (“KGK”), a subsidiary of Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), has been issued ...

Learn More
Press Releases

KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD

KGK SCIENCE APPLAUDS THE EFFORTS OF CONGRESS TO BEGIN REMOVING REGULATORY HURDLES FOR CBD KGK Science, the leader in providing human clinical trials and regulatory ...

Learn More
Blogs

What’s Coming Down the Pipe for Cannabis Research?

As our pursuit of cannabis knowledge continues to hasten, a large crop of innovative and interesting studies are sure to arise. But what should this ...

Learn More
Blogs

Regulatory Developments in the Cannabiz

With the public’s interest in cannabis getting higher than ever, the industry is changing at a breakneck pace — so much so that sometimes, it ...

Learn More
Blogs

Get the Scoop on Synbiotics

It’s no secret that dietary fibre and probiotics are both vital in the enhancement and maintenance of a healthy digestive system. However, the power they ...

Learn More
Blogs

Is the Industry’s Insight into CBD Half-Baked?

“There is a knowledge gap in our current understanding of Cannabidiol.” This month, cannabis experts were able to pipe up about the challenges surrounding the ...

Learn More
Whitepapers

Three Cs to Getting Value from Your Clinical Trial

The dietary supplement industry continues to grow despite potentially restrictive regulations and an increasing burden on the healthcare system. The global market for supplements increased ...

Download
Blogs

Budding Research: Conducting Clinical Cannabis Trials in Canada

It’s no secret that cannabis — also known as “marijuana,” “pot,” and in some circles, “whacky tabacky” — isn’t just for so-called “stoners.” With its ...

Learn More
Blogs

Shifting Paradigms: Discussing the State of Global Health Care with Dr. Mal Evans

“We need to challenge regulatory guidelines that require natural health products to behave similarly to drugs.” Dr. Mal Evans, our CSO, recently spoke at a ...

Learn More
Blogs

CBD and the Microbiome

Cannabis, commonly known as marijuana, is a botanical that has been used as alternative medicine in many cultures for several centuries. The plant produces over ...

Learn More
Press Releases

KGK Science Joins the Natural Products Association as a New Board Member

“The Time is Right for Us to Be a Leader at the Table in Those Board Discussions” London, ON – As part of the growth ...

Learn More
Blogs

I’d Like to Conduct Research on My Product. What Now?

How do you differentiate your product on the market? Is it by having a superior quality formulation compared to your competitors’? Or by having an ...

Learn More
Blogs

Cannabis Safety

Legalizing cannabis for recreational purposes has opened doors to serious debates regarding the safety and efficacy of its use. The two most important components of ...

Learn More
Blogs

The 2018 Farm Bill and the Legality of CBD in the United States

This new year holds the promise of significant changes in the landscape of the hemp industry in the United States. Monumental events of 2018 set ...

Learn More
Press Releases

KGK Science Inc. Announces Appointment of Stephen Holmes to CFO/COO and Ashley ten Haaf to…

KGK SCIENCE INC. ANNOUNCES APPOINTMENTS OF STEPHEN HOLMES TO CFO &COO AND ASHLEY TEN HAAF TO DIRECTOR OF CLINICAL OPERATIONS London, Ontario, September 10, 2018 ...

Learn More
Press Releases

KGK Science Inc. Announces Appointment of Mal Evans Ph.D to Chief Scientific Officer

KGK SCIENCE INC. ANNOUNCES APPOINTMENT OF MAL EVANS PH.D TO CHIEF SCIENTIFIC OFFICER London, Ontario, August 21, 2018 – Najla Guthrie, President & CEO, of KGK Science ...

Learn More
Press Releases

ChromaDex Clinical Trial Studying NIAGEN® Well Underway, With Eight Additional Collaborative Human

IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for ...

Learn More
Press Releases

KGK Synergize Inc. To Run Half Marathon In Support Of Vitamin Angels

LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating ...

Learn More
Press Releases

Next Pharmaceuticals Acquires Sytrinol

SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize.

Learn More
Press Releases

KGK Synergize Inc. Welcomes Angela Kelly To Our Team!

LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased ...

Learn More
Press Releases

KGK Synergize Inc. Announces Settlement Of Its Lawsuit With Sourceone Global Partners, Inc.

LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement ...

Learn More
Press Releases

Dr. Mal Evans Has Been Selected As The Recipient Of The 2010-2011 Wil Award

LONDON, ON, JUNE 28, 2011 –Recently, Dr. Mal Evans has been selected as the recipient of the 2010-2011 WIL Award which recognizes individuals and /or ...

Learn More
Uncategorized

Journal of Dietary Supplements, 7, 314–324.

A randomized, double-blind, crossover study on the pharmacokinetics of a novel formulation of CoQ10 with pyridoxal 5′-phosphate and phosphatidyl choline. Evans, M., Sharma, P., & Guthrie ...

Learn More
Press Releases

New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid

Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf

Learn More

We're sorry, no results were found.